| Trial ID: | L2262 |
| Source ID: | NCT00786825
|
| Associated Drug: |
Somatostatin
|
| Title: |
Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 Tesla
|
| Acronym: |
Glycogen
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00786825/results
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: somatostatin
|
| Outcome Measures: |
Primary: Brain Glycogen Turnover Rate, 1 month |
|
| Sponsor/Collaborators: |
Sponsor: University of Minnesota
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
|
| Start Date: |
2004-12
|
| Completion Date: |
2017-12
|
| Results First Posted: |
2019-12-18
|
| Last Update Posted: |
2019-12-18
|
| Locations: |
University of Minnesota, Minneapolis, Minnesota, 55414, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00786825
|
